Are anti-TNF 'non-responders' being classified correctly?

Real-world study finds some of the patients appear to have low disease activity

The way physicians are classifying some rheumatoid arthritis patients as ‘non-responders’ to anti-TNFs suggests there is room for improvement in adherence to guidelines, Canadian researchers say.